NAYA Biosciences (NAYA) - Uzoq muddatli qarzning kapitalga nisbati
Xalqaro mojarolar NAYA Biosciences (NAYA) uchun global ilmiy sherikliklar va biomateriallar logistikasiga to'sqinlik qilmoqda. Ushbu narxlar grafigi moliyaviy barqarorligi foyda yo'qligi sababli rezervlarning kamayishi bilan cheklangan NAYA Biosciences (NAYA) dinamikasini aks ettiradi. Xatarlar biotexnologiya sektoridagi kapital uchun shiddatli raqobat tufayli kuchaymoqda, bu yerda muvaffaqiyatsiz sinovlar aktivlar qiymatini yo'q qilishi mumkin va joriy ko'rsatkich 2.76 darajasida turibdi.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_NAYA_-_NAYA-Biosciences_-_Long-Term-Debt-to-Equity "nayabiosciences.com (NAYA): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi 04.07.2022dan 28.04.2025gacha | 👁️GURU.Markets👁️")
NAYA Biosciences kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati NAYA Biosciences|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati nayabiosciences.com|NAYA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati NAYA Biosciences Inc.|NAYA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari NAYA Biosciences|Tezkor likvidlik koeffitsiyenti nayabiosciences.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
Kompaniyaning umumiy tahlili:NAYA Biosciences Inc - NAYA
NAYA Biosciences kompaniyasining innovatsion onkologiya loyihalari rivojlanishning ilk bosqichlaridan o'tish uchun ulkan investitsiyalarni talab qiladi. Uzoq muddatli qarzning kapitalga nisbati bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbati sifatida hisoblanadi. Grafikdagi ushbu nisbatning dinamikasi emitentning qarz moliyalashtirishga qanchalik bog'liqligini ko'rsatadi. Daromad mavjud bo'lmagan holatlarda, past nisbatlar pul oqimi yetishmovchiligi xavfini minimallashtiradi. Bu kompaniyaning moliyaviy mustaqilligini saqlab qolish uchun juda muhimdir.
Muhim raqobatchilar
Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AURA (Aura Biosciences)|CADL (candeltx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ARAY (Accuray Inc.)|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACTU: Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR - Uzoq muddatli qarzning kapitalga nisbati|tuhurabio.com (HURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protara Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio WHWK|Uzoq muddatli qarzning o'z kapitaliga nisbati TScan Therapeutics (TCRX)|championsoncology.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati XBIT (XBiotech)|Uzoq muddatli qarzning kapitalga nisbati CEL-SCI Corp. CVM|OSTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Radiopharm Theranostics Ltd|ARTV: Uzoq muddatli qarzning kapitalga nisbati|Adlai Nortye (ANL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati VERU|TPST: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XLO|Uzoq muddatli qarzning o'z kapitaliga nisbati RENB (renovarobio.com)|Uzoq muddatli qarzning kapitalga nisbati MURA (Mural Oncology)|Uzoq muddatli qarzdorlikning kapitalga nisbati Kairos Pharma Limited (KAPA)|OKUR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati CytoMed Therapeutics|curis.com (CRIS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|APLM - Uzoq muddatli qarzdorlikning kapitalga nisbati|THAR (Tharimmune, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Advanced Biomed Corp (ADVB)|Uzoq muddatli qarzning kapitalga nisbati GNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati calidibio.com|Uzoq muddatli qarzning kapitalga nisbati SBFM (Sunshine Biopharma)|Xenetic Biosciences Inc. (XBIO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SLRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|PPBT (purple-biotech.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|AONC: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd.|CKPT (Checkpoint Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Elevation Oncology Inc. ELEV|Uzoq muddatli qarzning o'z kapitaliga nisbati iCAD, Inc. (ICAD)|Uzoq muddatli qarzdorlikning kapitalga nisbati ikenaoncology.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Notable Labs NTBL|VIRX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MorphoSys Corp - Uzoq muddatli qarzning kapitalga nisbati|AAPGV - Uzoq muddatli qarzning kapitalga nisbati